Most Watched Onclivetv
Dr. Roland on Findings From a Phase 2 Study With Neoadjuvant Checkpoint Blockade in Sarcoma
Wed, 2nd Sep 20
Dr. Pennell on the Evolution of Targeting HER2 in Lung Cancer
Wed, 2nd Sep 20
Dr. VanderWalde on Utility of Radiation Therapy in Rectal Cancer
Wed, 2nd Sep 20
Current and Future Directions in Metastatic Pancreatic Cancer
Wed, 2nd Sep 20
Dr. Maddocks on Emerging Therapies in Follicular Lymphoma
Tue, 1st Sep 20
Dr. Richard on the Evolving Armamentarium in Multiple Myeloma
Tue, 1st Sep 20
Dr. Halfdanarson on the KEYNOTE-177 Trial in MSI-H/dMMR mCRC
Tue, 1st Sep 20
Dr. Han on the Importance of Risk Stratification in HER2+ Breast Cancer
Tue, 1st Sep 20
Dr. Alkharabsheh on the Goals of Treatment in MPNs
Tue, 1st Sep 20
Dr. Soliman the Utility of ADCs in Breast Cancer
Tue, 1st Sep 20
MURANO Trial Update in R/R CLL
Tue, 1st Sep 20
Utility of MRD Testing in CLL Management
Tue, 1st Sep 20
Dr. DiNardo on the FDA Approval of Oral Azacitidine in AML
Tue, 1st Sep 20
Dr. Grothey on Biomarkers to Inform Metastatic CRC Treatment Decisions
Tue, 1st Sep 20
Dr. Richter on the Utility of Isatuximab in Relapsed/Refractory Myeloma
Tue, 1st Sep 20
Forged Through Fire: Nurses Are More Needed Than Ever Before
Tue, 1st Sep 20
Dr. Gronchi on the Toxicity Profile of Trabectedin Plus Radiotherapy in Sarcoma
Tue, 1st Sep 20
Dr. O’Regan on the Utility of CDK4/6 Inhibitors in Breast Cancer
Mon, 31st Aug 20
Dr. Hamilton on Recent Advances in HER2+ Breast Cancer
Mon, 31st Aug 20
Dr. Lai on the Potential Benefits of Venetoclax in AML
Mon, 31st Aug 20